| 1. |
- Engert, Andreas, et al.
(författare)
-
The European Hematology Association Roadmap for European Hematology Research : a consensus document
- 2016
-
Ingår i: Haematologica. - Pavia, Italy : Ferrata Storti Foundation (Haematologica). - 0390-6078 .- 1592-8721. ; 101:2, s. 115-208
-
Tidskriftsartikel (refereegranskat)abstract
- The European Hematology Association (EHA) Roadmap for European Hematology Research highlights major achievements in diagnosis and treatment of blood disorders and identifies the greatest unmet clinical and scientific needs in those areas to enable better funded, more focused European hematology research. Initiated by the EHA, around 300 experts contributed to the consensus document, which will help European policy makers, research funders, research organizations, researchers, and patient groups make better informed decisions on hematology research. It also aims to raise public awareness of the burden of blood disorders on European society, which purely in economic terms is estimated at (sic)23 billion per year, a level of cost that is not matched in current European hematology research funding. In recent decades, hematology research has improved our fundamental understanding of the biology of blood disorders, and has improved diagnostics and treatments, sometimes in revolutionary ways. This progress highlights the potential of focused basic research programs such as this EHA Roadmap. The EHA Roadmap identifies nine 'sections' in hematology: normal hematopoiesis, malignant lymphoid and myeloid diseases, anemias and related diseases, platelet disorders, blood coagulation and hemostatic disorders, transfusion medicine, infections in hematology, and hematopoietic stem cell transplantation. These sections span 60 smaller groups of diseases or disorders. The EHA Roadmap identifies priorities and needs across the field of hematology, including those to develop targeted therapies based on genomic profiling and chemical biology, to eradicate minimal residual malignant disease, and to develop cellular immunotherapies, combination treatments, gene therapies, hematopoietic stem cell treatments, and treatments that are better tolerated by elderly patients.
|
|
| 2. |
- Balduini, Carlo, et al.
(författare)
-
The EHA research roadmap : Platelet disorders
- 2021
-
Ingår i: HemaSphere. - 2572-9241. ; 5:7
-
Forskningsöversikt (refereegranskat)abstract
- In 2016, the European Hematology Association (EHA) published the EHA Roadmap for European Hematology Research1 aiming to highlight achievements in the diagnostics and treatment of blood disorders, and to better inform European policy makers and other stakeholders about the urgent clinical and scientific needs and priorities in the field of hematology. Each section was coordinated by 1 to 2 section editors who were leading international experts in the field. In the 5 years that have followed, advances in the field of hematology have been plentiful. As such, EHA is pleased to present an updated Research Roadmap, now including 11 sections, each of which will be published separately. The updated EHA Research Roadmap identifies the most urgent priorities in hematology research and clinical science, therefore supporting a more informed, focused, and ideally a more funded future for European hematology research. The 11 EHA Research Roadmap sections include Normal Hematopoiesis; Malignant Lymphoid Diseases; Malignant Myeloid Diseases; Anemias and Related Diseases; Platelet Disorders; Blood Coagulation and Hemostatic Disorders; Transfusion Medicine; Infections in Hematology; Hematopoietic Stem Cell Transplantation; CAR-T and Other Cellbased Immune Therapies; and Gene Therapy.
|
|
| 3. |
- Meiland, Franka J., et al.
(författare)
-
COGKNOW Development and evaluation of an ICT-device for people with mild dementia
- 2007
-
Ingår i: Medical and Care Compunetics 4. ; , s. 166-177
-
Konferensbidrag (refereegranskat)abstract
- Dementia is a progressive, chronic disease affecting 5% of all persons above 65 and over 40% of people over 90. The aim of the COGKNOW project is to achieve a breakthrough with research that addresses the needs of those with dementia, particularly those with mild dementia living in the community. This entails cognitive reinforcement in four main areas: helping people to remember, helping to maintain social contact, helping with performing daily life and recreational activities and finally enhance feelings of safety. Based on a sound foundation of needs reported in dementia literature, workshops and individual interviews have been carried out with dementia sufferers and their carers in three European countries. A ranked analysis of information from workshops and interviews, and the state of the art of successful ICT solutions will be the basis for formulating the functionalities of the technical solution and for the development of a cognitive prosthetic device with associated services for people with mild dementia. The research and evaluation will be conducted from human factors, technology, and business perspectives in three phases of one year each. In this paper we discuss the design of the COGKNOW project, the first results of the user needs inquiry workshops and the ICT solutions the COGKNOW project will focus on in the first year.
|
|
| 4. |
- Meiland, Franka J., et al.
(författare)
-
COGKNOW: Development of an ICT device to support people with dementia
- 2007
-
Ingår i: Journal on Information Technology in Healthcare. - 1479-649X. ; 5:5, s. 324-334
-
Tidskriftsartikel (refereegranskat)abstract
- Objective: To develop a successful user-validated cognitive prosthetic device with associated services to help persons with mild dementia.Setting: The ICT solution will be developed by a consortium of eleven institutes in eight countries in Europe. It will be tested and evaluated by users (persons with dementia and their carers) in 3 European cities - Amsterdam, Belfast and Luleå.Methods: To identify and analyse the needs of persons with dementia, workshops and interviews were conducted with Alzheimer patients suffering from mild dementia, and their carers in three European cities. A literature search was also performed to identify existing proven effective ICT solutions for persons with dementia.Results: The most important needs and the most preferred ICT solutions identified by participants were (i) Activity reminders e.g. for eating meals; (ii) Item locators; (iii) Picture dialling to keep in contact with family and friends; (iv) Support for pleasure activities; (v) Enhancement of feelings of safety. Conclusion: Based on the needs identified, a prototype solution will be built, tested and modified as an iterative process. The device will ultimately be evaluated to see if it can enhance feelings of autonomy and quality of life of persons with dementia.
|
|
